DOCSLIB.ORG

CITED2-Mediated Mechanotransduction and Its Use for Chondroprotection

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CITED2-Mediated Mechanotransduction and Its Use for Chondroprotection City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 10-2014 CITED2-Mediated Mechanotransduction and its use for Chondroprotection Daniel J. Leong Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/444 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] CITED2-Mediated Mechanotransduction and its use for Chondroprotection By Daniel J. Leong A dissertation submitted to the Graduate Faculty in Biomedical Engineering in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2014 Copyright by Daniel Leong 2014 This manuscript has been read and accepted for the Graduate Faculty in Biomedical Engineering in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. ____________________________________________________________________________ Sihong Wang, PhD – Chair of Examining Committee Date Department of Biomedical Engineering, The City University of New York ____________________________________________________________________________ Ardie Walser, PhD, Executive Officer Date The City University of New York Hui (Herb) B. Sun, PhD – Dissertation Advisor Departments of Orthopaedic Surgery and Radiation Oncology Albert Einstein College of Medicine Luis Cardoso, PhD – Dissertation Advisor Department of Biomedical Engineering, The City University of New York Mitchell B. Schaffler, PhD – Dissertation Committee Member Department of Biomedical Engineering, The City University of New York Robert J. Majeska, PhD – Dissertation Committee Member Department of Biomedical Engineering, The City University of New York Abstract of the Dissertation CITED2-Mediated Mechanotransduction and its use for Chondroprotection By Daniel J. Leong Doctor of Philosophy In Biomedical Engineering The City University of New York 2014 Advisors: Hui B. Sun, PhD and Dr. Luis Cardoso, PhD Novel prevention and therapeutic treatment for cartilage degradation is urgently called for, as cartilage degradation is a hallmark for arthritic diseases including osteoarthritis (OA) and rheumatoid arthritis (RA), and there is a high incidence of arthritis-related disability and high medical costs. While both underuse (e.g. physically inactive lifestyle) and overuse (e.g. high impact or intense repetitive joint use as seen in certain sports) are risk factors for cartilage degradation, recent studies highlight that dynamic moderate loading is associated with reduced incidence of developing OA. Exercise is prescribed in most cases at moderate levels for both OA and RA patients, and accumulating studies demonstrate appropriate exercise maintains cartilage homeostasis and may exert a role in chondroprotection, but the mechanisms underlying how mechanical signals are translated into chondroprotective actions are largely unknown. Identifying the molecules that mediate mechanotransduction and its mechano-responsive nature will not only provide a biomechanical basis for developing more effective mechanical loading- based exercises for chondroprotection, but also can provide novel targets or molecular switches to develop chemical-based modalities for disease treatment. The overall objectives of this dissertation were to determine the mechanical response of transcriptional regulator CBP/p300 Interacting Transactivator with ED-rich Tail 2 (CITED2) to various mechanical loading regimes, elucidating CITED2-mediated chondroprotective pathways, and determining the potential of CITED2 as a target for the prevention and treatment of cartilage degradation in arthritis. The global hypothesis was that CITED2 mediates a mechanical pathway of chondroprotection, CITED2 is required for cartilage integrity, and restoration or increasing levels of CITED2 exerts efficacy in the prevention and treatment of cartilage degradation. This hypothesis was tested with four specific aims: 1) To determine the gene expression response of CITED2 to various mechanical loading regimes, and the role of CITED2 in mediating mechanical regulation of matrix metalloproteinases (MMPs), 2) To determine the CITED2- mediated loading-induced pathway and test whether it is required for loading-induced downregulation of MMPs, 3) To determine whether deficiency of CITED2 is a causal factor for cartilage degradation in arthritic diseases such as OA, and 4) Test the concept of CITED2 as a target for chondroprotection. The key findings of this dissertation include: 1) CITED2 expression is induced by moderate dynamic loading in chondrocytes in an intensity- and duration-dependent manner, and the upregulation of CITED2 is sustained for at least 12 hours after loading. The induction of CITED2 is required for the downregulation of MMPs (i.e. MMP-2, -3, and -13), 2) Dynamic moderate loading induces CITED2 by activating p38δ, which in turn triggers Sp1 and HIF-1α to transactivate CITED2. CITED2 competes with MMP transactivator Ets-1 for binding to limiting amounts of co-factor p300, resulting in repression of MMP expression. 3) Deficiency of CITED2 is associated with cartilage degradation in human OA and disease progression of post- traumatic OA in mice subject to destabilization of the medial meniscus (DMM). Experimental knockdown of CITED2 caused cartilage degradation and deletion of CITED2 in adult cartilage not only resulted in an early OA phenotype, but also accelerated the disease progression of cartilage degradation in DMM mice, revealing a chondroprotective role of CITED2, which is required for cartilage integrity maintenance. 4) Restoring levels of CITED2, via gene transfer or small molecule epigallocatechin gallate (EGCG), exerts efficacy in slowing cartilage degradation in RA and OA mouse models. Together, these studies provide feasibility for developing CITED2-activation-based therapies for the prevention and treatment of cartilage degradation. Acknowledgements First and foremost, I would like to thank my mentor Dr. Herb Sun. I am so grateful to have had the opportunity to learn from him, and appreciate all his contributions of time, ideas, and funding to make my Ph.D. experience productive and stimulating. Herb’s enthusiasm for research was contagious and motivational. I am so thankful for the excellent example he provided to be a successful scientist and leader. I am also very grateful for my co-mentor Dr. Luis Cardoso for his guidance, support, and generosity. I truly appreciate my dissertation committee Dr. Mitchell Schaffler, Dr. Robert Majeska, and Dr. Sihong Wang who have fostered my scientific growth with their tough questions, insightful comments, and encouragement. I would like to thank all my colleagues and friends who not only donated their time and expertise to teach me but also provided camaraderie during all those long sessions in the lab, including: Yonghui Li, Ph.D, Zhengzhe Li, PhD (Big Li), Damien Laudier, Phil Nasser, Melissa Ramcharan, Brad Herman, PhD, David Fung, PhD, Jonathan Lee, MD, Zhiyong He, PhD, Takuya Ruike, MD, Nelly Andarawis-Puri, PhD, Jedd Seresky, MD, PhD, Stephen Ros MD, PhD, Marwa Choudhury, Justin Tang, MD, Lin Xu, MD, and Fawzy Saad, PhD. Last and not least, I would like to thank my family and friends for all their love, encouragement, and unwavering support for all my pursuits. Table of Contents List of Figures ……………………………………………………………………………... i List of Abbreviations ……………………………………………………………………… ix Chapter 1. Introduction: Articular joints, cartilage homeostasis, mechanotransduction and CITED2 1.1. Research Significance ………………………………………………………………. 1 1.2. Joint structure and physiology ………………………………………………………. 2 1.3. Cartilage degradation ……………………………………………………………….. 4 1.4. Mechanical loading and joint health ……………………………………………….. 14 1.5. CITED2 …………………………………………………………………………….. 18 Chapter 2. Hypothesis and Specific Aims ……………………………………………….. 24 Chapter 3. Biomechanical response of CITED2 and role of CITED2 in loading- induced downregulation of MMPs Abstract …………………………………………………………………………….. 27 Introduction …………………………………………………………………………. 29 Methods and Materials ……………………………………………………………… 31 Results ……………………………………………………………………………… 33 Discussion …………………………………………………………………………. 35 Figures ……………………………………………………………………………… 38 Chapter 4. Physiologic Loading Of Joints Prevents Cartilage Degradation Through CITED2 Abstract …………………………………………………………………………….. 42 Introduction …………………………………………………………………………. 43 Methods and Materials ……………………………………………………………… 44 Results ……………………………………………………………………………… 51 Discussion …………………………………………………………………………. 59 Figures ……………………………………………………………………………… 63 Chapter 5. CITED2 is required for cartilage homeostasis: deletion of CITED2 in mice leads to osteoarthritis Abstract …………………………………………………………………………….. 71 Introduction …………………………………………………………………………. 73 Methods and Materials ……………………………………………………………… 74 Results ……………………………………………………………………………… 75 Discussion …………………………………………………………………………. 78 Figures ……………………………………………………………………………… 80 Chapter 6. The Use of CITED2 for Chondroprotection Abstract …………………………………………………………………………….. 85 Introduction …………………………………………………………………………. 86 Methods and Materials ……………………………………………………………… 87 Results ……………………………………………………………………………… 89 Discussion …………………………………………………………………………. 92 Figures ……………………………………………………………………………… 96 Chapter 7. Global Discussion …………………………………………………………….
Load more

Recommended publications
  • Cited2 Controls Left-Right Patterning and Heart Development Through a Nodal-Pitx2c Pathway
    ARTICLES Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway Simon D Bamforth1,6,Jose´ Braganc¸a1,6, Cassandra R Farthing1,6,Ju¨rgen E Schneider1, Carol Broadbent1, Anna C Michell1, Kieran Clarke2, Stefan Neubauer1, Dominic Norris3, Nigel A Brown4, Robert H Anderson5 & Shoumo Bhattacharya1 Malformations of the septum, outflow tract and aortic arch are the most common congenital cardiovascular defects and occur in mice lacking Cited2, a transcriptional coactivator of TFAP2. Here we show that Cited2–/– mice also develop laterality defects, including right isomerism, abnormal cardiac looping and hyposplenia, which are suppressed on a mixed http://www.nature.com/naturegenetics genetic background. Cited2–/– mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays. We propose that an abnormal Nodal-Pitx2c pathway represents a unifying mechanism for the cardiovascular malformations observed in Cited2–/– mice, and that such malformations may be the sole manifestation of a laterality defect. Genetic, developmental and molecular studies over the past decade transcription factors by linking them to EP300 and CREBBP9,15,16. have identified a number of DNA-binding transcription factors that Mutations in Tcfap2a and TFAP2B (Char syndrome) result in cardiac have key roles in cardiac morphogenesis and in the pathogenesis of and aortic arch malformations17,18, suggesting that coactivation of common congenital heart defects1. The role of transcriptional coacti- TFAP2 by CITED2, EP300 and CREBBP is necessary for the normal vators, molecules that connect DNA-binding transcription factors to development of these structures9.
    [Show full text]
  • Wilms' Tumor Gene 1 in Different Types of Cancer
    UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New Series No.1717 ISSN 0346-6612 ISBN 978-91-7601-263-5 Wilms’ tumor gene 1 in different types of cancer Xingru Li Department of Medical Biosciences, Clinical Chemistry Umeå University, Sweden Umeå 2015 Copyright © 2015 Xingru Li ISBN: 978-91-7601-263-5 ISSN: 0346-6612 Printed by: Print & Media Umeå, Sweden, 2015 To my family Table of Contents Abstract .......................................................................................................... 1 Original Articles ............................................................................................. 2 Abbreviations ................................................................................................. 3 Introduction .................................................................................................... 4 WT1 (Wilms’ tumor gene 1) ...................................................................... 4 Structure of WT1 ..................................................................................... 4 WT1, the transcription factor ................................................................. 5 WT1 and its interacting partners ............................................................ 5 WT1 function .......................................................................................... 8 The tumor suppressor ........................................................................ 8 An oncogene ...................................................................................... 8 Mutations and
    [Show full text]
  • Brief Report
    BRIEF REPORT CITED2 mutations potentially cause idiopathic premature ovarian failure DORA JANETH FONSECA, DIEGO OJEDA, BESMA LAKHAL, RIM BRAHAM, STEFANIE EGGERS, ERIN TURBITT, STEFAN WHITE, SONIA GROVER, GARRY WARNE, MARGARET ZACHARIN, ^ ALEXANDRA NEVIN LAM, HANENE LANDOLSI, HATEM ELGHEZAL, ALI SAAD, CARLOS MARTIN RESTREPO, MARC FELLOUS, ANDREW SINCLAIR, PETER KOOPMAN, and PAUL LAISSUE BOGOTA, COLOMBIA; SOUSSE, TUNISIA; MELBOURNE AND BRISBANE, AUSTRALIA; AND PARIS, FRANCE Anomalies in gonadal development in a mouse knockout model of Cited2 have been recently described. In Cited2 2/2 female gonads, an ectopic cell migration was observed and the female program of sex determination was transiently delayed. We hypothesize that, in humans, this temporary inhibition of genes should be sufficient to provoke a developmental impairment of the female gonads, conducive to prema- ture ovarian failure (POF). To establish whether CITED2 mutations are a common cause of the disease, we performed a mutational analysis of this gene in a panel of patients with POF and in a group of control women with normal fertility. We amplified and di- rectly sequenced the complete open reading frame of CITED2 in 139 patients with POF and 290 controls. This study revealed 5 synonymous and 3 nonsynonymous vari- ants. Among these, 7 are novel. The nonsynonymous variant c.604C.A (p.Pro202Thr) was found uniquely in 1 woman from the POF group. In silico analysis of this mutation indicated a potential deleterious effect. We conclude that mutations in CITED2 may be involved
    [Show full text]
  • Action by CITED2 in the Nucleus B Κ
    Negative Feedback Regulation of NF-κB Action by CITED2 in the Nucleus Xiwen Lou, Shaogang Sun, Wei Chen, Yi Zhou, Yuefeng Huang, Xing Liu, Yufei Shan and Chen Wang This information is current as of September 29, 2021. J Immunol 2011; 186:539-548; Prepublished online 22 November 2010; doi: 10.4049/jimmunol.1001650 http://www.jimmunol.org/content/186/1/539 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/11/22/jimmunol.100165 Material 0.DC1 References This article cites 45 articles, 19 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/186/1/539.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 29, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Negative Feedback Regulation of NF-kB Action by CITED2 in the Nucleus Xiwen Lou, Shaogang Sun, Wei Chen, Yi Zhou, Yuefeng Huang, Xing Liu, Yufei Shan, and Chen Wang NF-kB is a family of important transcription factors that modulate immunity, development, inflammation, and cancer.
    [Show full text]
  • Wt1 Directs the Lineage Specification of Sertoli and Granulosa Cells By
    © 2017. Published by The Company of Biologists Ltd | Development (2017) 144, 44-53 doi:10.1242/dev.144105 RESEARCH ARTICLE Wt1 directs the lineage specification of sertoli and granulosa cells by repressing Sf1 expression Min Chen1,*, Lianjun Zhang1,2,*, Xiuhong Cui1, Xiwen Lin1, Yaqiong Li1,2, Yaqing Wang3, Yanbo Wang1,2, Yan Qin1,2, Dahua Chen1, Chunsheng Han1, Bin Zhou4, Vicki Huff5 and Fei Gao1,‡ ABSTRACT Leydig cells and theca-interstitial cells are the steroidogenic cells Supporting cells (Sertoli and granulosa) and steroidogenic cells in male and female gonads, respectively. The steroid hormones (Leydig and theca-interstitium) are two major somatic cell types in produced by steroidogenic cells play essential roles in germ cell mammalian gonads, but the mechanisms that control their development and in maintaining secondary sexual characteristics. differentiation during gonad development remain elusive. In this Leydig cells first appear in testes at E12.5, whereas theca-interstitial study, we found that deletion of Wt1 in the ovary after sex cells are observed postnatally in the ovaries along with the determination caused ectopic development of steroidogenic cells at development of ovarian follicles. The origins of Leydig cells the embryonic stage. Furthermore, differentiation of both Sertoli and (Weaver et al., 2009; Barsoum and Yao, 2010; DeFalco et al., 2011) granulosa cells was blocked when Wt1 was deleted before sex and theca cells (Liu et al., 2015) have been studied previously. determination and most genital ridge somatic cells differentiated into However, the underlying mechanism that regulates the steroidogenic cells in both male and female gonads. Further studies differentiation between supporting cells and steroidogenic cells revealed that WT1 repressed Sf1 expression by directly binding to the during gonad development is poorly understood.
    [Show full text]
  • Gene Dosage Effects and Transcriptional Regulation of Early Mammalian Adrenal Cortex Development Pierre Val, & Amanda Swain
    Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development Pierre Val, & Amanda Swain To cite this version: Pierre Val, & Amanda Swain. Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development. Molecular and Cellular Endocrinology, Elsevier, 2010, 323 (1), pp.105. 10.1016/j.mce.2009.12.010. hal-00593434 HAL Id: hal-00593434 https://hal.archives-ouvertes.fr/hal-00593434 Submitted on 16 May 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Accepted Manuscript Title: Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development Authors: Pierre VAL, & Amanda Swain PII: S0303-7207(09)00618-2 DOI: doi:10.1016/j.mce.2009.12.010 Reference: MCE 7391 To appear in: Molecular and Cellular Endocrinology Please cite this article as: VAL, P., Swain, A., Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development, Molecular and Cellular Endocrinology (2008), doi:10.1016/j.mce.2009.12.010 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript.
    [Show full text]
  • Frequent Loss-Of-Heterozygosity in CRISPR-Cas9–Edited Early Human Embryos
    Frequent loss-of-heterozygosity in CRISPR-Cas9–edited COLLOQUIUM PAPER early human embryos Gregorio Alanis-Lobatoa, Jasmin Zohrenb, Afshan McCarthya, Norah M. E. Fogartya,c, Nada Kubikovad,e, Emily Hardmana, Maria Grecof, Dagan Wellsd,g, James M. A. Turnerb, and Kathy K. Niakana,h,1 aHuman Embryo and Stem Cell Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; bSex Chromosome Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; cCentre for Stem Cells and Regenerative Medicine, Guy’s Campus, King’s College London, SE1 9RT London, United Kingdom; dNuffield Department of Women’s and Reproductive Health, John Radcliffe Hospital, University of Oxford, OX3 9DU Oxford, United Kingdom; eJesus College, University of Oxford, OX1 3DW Oxford, United Kingdom; fAncient Genomics Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; gJuno Genetics, OX4 4GE Oxford, United Kingdom; and hThe Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EG Cambridge, United Kingdom Edited by Barbara J. Meyer, University of California, Berkeley, CA, and approved October 31, 2020 (received for review June 5, 2020) CRISPR-Cas9 genome editing is a promising technique for clinical homozygous WT embryos in both cases was not associated with applications, such as the correction of disease-associated alleles in use of the provided repair template for gene correction. Instead, somatic cells. The use of this approach has also been discussed in the authors suggest that in edited embryos the WT maternal the context of heritable editing of the human germ line. However, allele served as a template for the high-fidelity homology di- studies assessing gene correction in early human embryos report rected repair (HDR) pathway to repair the double-strand lesion low efficiency of mutation repair, high rates of mosaicism, and the caused by the Cas9 protein in the paternal allele (8).
    [Show full text]
  • CITED2 Mutation and Methylation in Children with Congenital Heart Disease
    Xu et al. Journal of Biomedical Science 2014, 21:7 http://www.jbiomedsci.com/content/21/1/7 RESEARCH Open Access CITED2 Mutation and methylation in children with congenital heart disease Min Xu1,3, Xiaoyun Wu1*, Yonggang Li2, Xiaofei Yang1,3, Jihua Hu1,3, Min Zheng1,3 and Jie Tian1 Abstract Background: The occurrence of Congenital Heart Disease (CHD) is resulted from either genetic or environmental factors or the both. The CITED2 gene deletion or mutation is associated with the development of cardiac malformations. In this study, we have investigated the role of CITED2 gene mutation and methylation in the development of Congenital Heart Disease in pediatric patients in China. Results: We have screened 120 pediatric patients with congenital heart disease. Among these patients, 4 cases were detected to carry various CITED2 gene heterozygous mutations (c.550G > A, c.574A > G, c.573-578del6) leading correspondingly to the alterations of amino acid sequences in Gly184Ser, Ser192Gly, and Ser192fs, respectively. No CITED2 gene mutations were detected in the control group. At the same time, we found that CITED2 mutations could inhibit TFAP2c expression. In addition, we have demonstrated that abnormal CITED2 gene methylation was detected in most of the tested pediatric patients with CHD, which leads to a decrease of CITED2 transcription activities. Conclusions: Our study suggests that CITED2 gene mutations and methylation may play an important role in the development of pediatric congenital heart disease. Keywords: CITED2, Mutation, Methylation, Congenital heart disease Background target genes, which is one of the potential causes of gene Congenital Heart Disease (CHD) is the most common silence and disease [8].
    [Show full text]
  • Cited2 Modulates TGF-B-Mediated Upregulation of MMP9
    Oncogene (2006) 25, 5547–5560 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc ORIGINAL ARTICLE Cited2 modulates TGF-b-mediated upregulation of MMP9 Y-T Chou1, H Wang1, Y Chen2, D Danielpour1 and Y-C Yang1 1Department of Pharmacology and Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA and 2Department of Medical and Molecular Genetics, Indiana University School of Medicine and the Walther Cancer Institute, Indianapolis, IN, USA Cited (CBP/p300-interacting transactivators with gluta- domain) gene family consists of four nuclear proteins mic acid (E)/aspartic acid (D)-rich C-terminal domain) 2, – Cited1 (formerly MSG1) (Shioda et al., 1996, 1997; which is a CBP/p300-binding transcription co-activator Dunwoodie et al., 1998), Cited2 (formerly MRG1/ without typical DNA-binding domains, has been impli- p35srj) (Shioda et al., 1997; Dunwoodie et al., 1998; cated in control of cell growth and malignant transforma- Sun et al., 1998; Bhattacharya et al., 1999; Leung et al., tion in Rat1 cells. In this report, we provide evidence that 1999), Cited3 (Andrews et al., 2000), and Cited4 Cited2 is an important regulator of transforming growth (formerly MRG2) (Braganca et al., 2002). Members of factor (TGF)-b signaling. Overexpression of Cited2 this family function as transcriptional co-activators enhanced TGF-b-mediated transcription of a Smad- without classical DNA-binding domains. Cited2 Binding Element-containing luciferase reporter construct, interacts with the LIM domain of Lhx2 to enhance SBE4-Luc. This may occur through a direct physical Lhx2-dependent transcription of LH/FSH glycoprotein association of Cited2 with Smads 2 and 3, as supported by a-subunit genes (Glenn and Maurer, 1999).
    [Show full text]
  • Genome and Epigenome Analysis of Monozygotic Twins Discordant For
    Lyu et al. BMC Genomics (2018) 19:428 https://doi.org/10.1186/s12864-018-4814-7 RESEARCHARTICLE Open Access Genome and epigenome analysis of monozygotic twins discordant for congenital heart disease Guoliang Lyu1†, Chao Zhang1,3†, Te Ling1†, Rui Liu2, Le Zong1, Yiting Guan1, Xiaoke Huang1, Lei Sun1, Lijun Zhang1, Cheng Li3*, Yu Nie2* and Wei Tao1* Abstract Background: Congenital heart disease (CHD) is the leading non-infectious cause of death in infants. Monozygotic (MZ) twins share nearly all of their genetic variants before and after birth. Nevertheless, MZ twins are sometimes discordant for common complex diseases. The goal of this study is to identify genomic and epigenomic differences between a pair of twins discordant for a form of congenital heart disease, double outlet right ventricle (DORV). Results: A monoamniotic monozygotic (MZ) twin pair discordant for DORV were subjected to genome-wide sequencing and methylation analysis. We identified few genomic differences but 1566 differentially methylated regions (DMRs) between the MZ twins. Twenty percent (312/1566) of the DMRs are located within 2 kb upstream of transcription start sites (TSS), containing 121 binding sites of transcription factors. Particularly, ZIC3 and NR2F2 are found to have hypermethylated promoters in both the diseased twin and additional patients suffering from DORV. Conclusions: The results showed a high correlation between hypermethylated promoters at ZIC3 and NR2F2 and down- regulated gene expression levels of these two genes in patients with DORV compared to normal controls, providing new insight into the potential mechanism of this rare form of CHD. Keywords: CHD, MZ twins, ZIC3, NR2F2,DNAmethylation,RRBS,WGS Background During the normal development of the heart, the out- Congenital heart disease (CHD) is the leading flow tract initially connects exclusively with the primitive non-infectious cause of death in infants.
    [Show full text]
  • Identification and Quantification of Novel RNA Isoforms in Horn Cancer
    3 Biotech (2016) 6:259 DOI 10.1007/s13205-016-0577-5 ORIGINAL ARTICLE Identification and quantification of novel RNA isoforms in horn cancer of Bos indicus by comprehensive RNA-Seq 1 1 1 Subhash J. Jakhesara • Prakash G. Koringa • Neelam M. Nathani • Chaitanya G. Joshi1 Received: 17 October 2016 / Accepted: 26 November 2016 / Published online: 7 December 2016 Ó The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Horn cancer (HC) is a squamous cell carcinoma Keywords Horn cancer Á Alternative splicing Á GS-FLX of horn, commonly observed in Bos indicus of the Asian Titanium Á Transcriptome profiling Á Splice isoform countries. To elucidate the complexity of alternative splicing present in the HC, high-throughput sequencing and Abbreviations analysis of HC and matching horn normal (HN) tissue were HC Horn cancer carried out. A total of 535,067 and 849,077 reads were HN Horn normal analysed after stringent quality filtering for HN and HC, AS Alternative splicing respectively. Cufflinks pipeline for transcriptome analysis EST Expressed sequence tag revealed 4786 novel splice isoforms comprising 2432 KEGG Kyoto encyclopedia of genes and genomes exclusively in HC, 2055 exclusively in HN and 298 in both DAVID Database for annotation, visualization and the conditions. Based on pathway clustering and in silico integrated discovery verification, 102 novel splice isoforms were selected and BLAT Blast-like alignment tool further analysed with respect to change in protein sequence IGV Integrated genome viewer using Blastp. Finally, fourteen novel splicing events sup- GO Gene ontology ported both by Cufflinks and UCSC genome browser were NMD Nonsense-mediated decay selected and confirmed expression by RT-qPCR.
    [Show full text]
  • CITED2 Modulation of Trophoblast Cell Differentiation: Insights from Global Transcriptome Analysis
    REPRODUCTIONRESEARCH CITED2 modulation of trophoblast cell differentiation: insights from global transcriptome analysis Kazuhiko Imakawa1,2, Pramod Dhakal2, Kaiyu Kubota2, Kazuya Kusama1, Damayanti Chakraborty2, M A Karim Rumi2 and Michael J Soares2 1Laboratory of Theriogenology and Animal Breeding, The University of Tokyo, Bunkyo-ku, Tokyo, Japan and 2Department of Pathology and Laboratory Medicine, Institute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA Correspondence should be addressed to K Imakawa; Email: [email protected] or M J Soares; Email: [email protected] Abstract Trophoblast stem (TS) cells possess the capacity to differentiate along a multi-lineage pathway yielding several specialized cell types. The regulatory network controlling trophoblast cell differentiation is poorly understood. Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain, 2 (CITED2) has been implicated in the regulation of placentation; however, we know little about how CITED2 acts to influence trophoblast cells. Rat Rcho-1 TS cells can be manipulated to proliferate or differentiate into specialized trophoblast lineages and are an excellent model for investigating trophoblast differentiation. CITED2 transcript and protein showed a robust induction during Rcho-1 TS cell differentiation. We used an shRNA knockdown approach to disrupt CITED2 expression in order to investigate its involvement in trophoblast cell differentiation. RNA-sequencing was used to examine the impact of CITED2 on trophoblast cell differentiation. CITED2 disruption affected the differentiating trophoblast cell transcriptome. CITED2 possessed a prominent role in the regulation of cell differentiation with links to several signal transduction pathways and to hypoxia-regulated and coagulation processes.
    [Show full text]